Long, Z.; Wu, X.; Luo, T.; Chen, X.; Huang, J.; Zhang, S.
Exploring the Molecular Mechanism of 1,25(OH)2D3 Reversal of Sorafenib Resistance in Hepatocellular Carcinoma Based on Network Pharmacology and Experimental Validation. Curr. Issues Mol. Biol. 2025, 47, 319.
https://doi.org/10.3390/cimb47050319
AMA Style
Long Z, Wu X, Luo T, Chen X, Huang J, Zhang S.
Exploring the Molecular Mechanism of 1,25(OH)2D3 Reversal of Sorafenib Resistance in Hepatocellular Carcinoma Based on Network Pharmacology and Experimental Validation. Current Issues in Molecular Biology. 2025; 47(5):319.
https://doi.org/10.3390/cimb47050319
Chicago/Turabian Style
Long, Zhiyan, Xiangyi Wu, Tianxin Luo, Xiaomei Chen, Jian Huang, and Shu Zhang.
2025. "Exploring the Molecular Mechanism of 1,25(OH)2D3 Reversal of Sorafenib Resistance in Hepatocellular Carcinoma Based on Network Pharmacology and Experimental Validation" Current Issues in Molecular Biology 47, no. 5: 319.
https://doi.org/10.3390/cimb47050319
APA Style
Long, Z., Wu, X., Luo, T., Chen, X., Huang, J., & Zhang, S.
(2025). Exploring the Molecular Mechanism of 1,25(OH)2D3 Reversal of Sorafenib Resistance in Hepatocellular Carcinoma Based on Network Pharmacology and Experimental Validation. Current Issues in Molecular Biology, 47(5), 319.
https://doi.org/10.3390/cimb47050319
